LON:BIOG

The Biotech Growth Trust (BIOG) Share Forecast, Price & News

GBX 835

+15.00 (+1.83%)

(As of 05/20/2022 01:17 PM ET)

Add

Compare

Today's Range: 818
▼
840
50-Day Range: 753
▼
940
52-Week Range: 722.37
▼
1,444

Volume: 225,345 shs
Average Volume: 105,614 shs
Market Capitalization: £341.70 million

P/E Ratio: N/A
Dividend Yield: N/A
Beta: N/A

30 days | 90 days | 365 days | Advanced Chart

Receive BIOG News and Ratings via Email

Sign-up to receive the latest news and ratings for The Biotech Growth Trust and its competitors with MarketBeat's FREE daily newsletter.

About The Biotech Growth Trust

The Biotech Growth Trust PLC is a closed ended equity mutual fund launched by Frostrow Capital LLP. It is co-managed by OrbiMed Capital LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the biotechnology sector. The fund invests in stocks of companies across all market capitalizations. It employs fundamental analysis to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotechnology Index. It was previously known as Finsbury Emerging Biotechnology Trust PLC. The Biotech Growth Trust PLC was formed on May 20, 1997 and is domiciled in the United Kingdom.

May 15, 2022 | nasdaq.com

What Stocks To Buy This Week? 4 Biotech Stocks To Know

May 14, 2022 | americanbankingnews.com

The Biotech Growth Trust (LON:BIOG) Stock Price Passes Below 50-Day Moving Average of $882.73

May 6, 2022 | americanbankingnews.com

The Biotech Growth Trust (LON:BIOG) Stock Crosses Below 50-Day Moving Average of $900.64

April 30, 2022 | uk.finance.yahoo.com

The Biotech Growth Trust Plc - Holding(s) in Company

December 9, 2021 | msn.com

Questor: biotech has been shunned this year despite the vaccines triumph – so buy these trusts

November 16, 2021 | finanznachrichten.de

The Biotech Growth Trust Plc - Directorate Change - Appointment of New Director

October 10, 2021 | fool.co.uk

The Oxford Nanopore share price soared at its IPO. Should I buy now or wait?

September 10, 2021 | finanznachrichten.de

The Biotech Growth Trust Plc - Correction: Transaction in Own Shares

August 30, 2021 | lse.co.uk

Biotech Gwth Share Chat

July 25, 2021 | fool.co.uk

3 UK growth stocks I’ve been buying in July

July 20, 2021 | nasdaq.com

July 12, 2021 | nasdaq.com

Looking for a Growth Stock? 3 Reasons Why Public Storage (PSA) is a Solid Choice

July 6, 2021 | bizjournals.com

MoCo biopharma Sirnaomics raises another nine-figure round

See More Headlines

Industry, Sector and Symbol

Stock Exchange: LON
Industry: Asset Management
Sub-Industry: N/A
Sector: Financial Services
Current Symbol: LON:BIOG
Previous Symbol
CUSIP: N/A
CIK: N/A
Web: www.biotechgt.com
Phone: +44-20-74264000
Fax: N/A
Employees: N/A
Year Founded: N/A

Sales & Book Value

Annual Sales: £-32.12 million
Price / Sales: -10.64
Cash Flow: GBX 9.30 per share
Price / Cash Flow: 89.78
Book Value: GBX 1,327 per share
Price / Book: 0.63

Profitability

EPS (Most Recent Fiscal Year): N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: 3.49
Current Ratio: 0.12
Quick Ratio: 0.12

Price-To-Earnings

Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A

Miscellaneous

Outstanding Shares: 40,921,700
Free Float: N/A
Market Cap: £341.70 million
Optionable: Not Optionable

Company Calendar

Today: 5/22/2022
Next Earnings (Estimated): 6/01/2022

MarketRank^™

Overall MarketRank^™

0.98 out of 5 stars

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for The Biotech Growth Trust.

4.3 Community Rank

Outperform Votes
The Biotech Growth Trust has received 82 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
The Biotech Growth Trust has received 46 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
The Biotech Growth Trust has received 64.06% “outperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about The Biotech Growth Trust and other stocks. Vote “Outperform” if you believe BIOG will outperform the S&P 500 over the long term. Vote “Underperform” if you believe BIOG will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
The Biotech Growth Trust does not currently pay a dividend.
Dividend Growth
The Biotech Growth Trust does not have a long track record of dividend growth.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, The Biotech Growth Trust insiders have not sold or bought any company stock.

0.6 Earnings and Valuation

Price to Earnings Ratio vs. the Market
The P/E ratio of The Biotech Growth Trust is -12.46, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of The Biotech Growth Trust is -12.46, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
The Biotech Growth Trust has a P/B Ratio of 0.63. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

The Biotech Growth Trust (LON:BIOG) Frequently Asked Questions

When is The Biotech Growth Trust's next earnings date?: The Biotech Growth Trust is scheduled to release its next quarterly earnings announcement on Wednesday, June 1st 2022.
View our earnings forecast for The Biotech Growth Trust.
Who are The Biotech Growth Trust's key executives?: The Biotech Growth Trust's management team includes the following people:
Mr. Samuel David Isaly, Portfolio Mang. (Age 77)
Who are some of The Biotech Growth Trust's key competitors?: Some companies that are related to The Biotech Growth Trust include Hipgnosis Songs Fund (SONG), JPMorgan American Investment Trust (JAM), The Bankers Investment Trust (BNKR), TR Property Investment Trust (TRY), BH Macro (BHMG), Rathbones Group (RAT), BlackRock World Mining Trust (BRWM), Octopus Titan VCT (OTV2), New Mountain Finance (NMFC), Impax Environmental Markets (IEM), Grenke (GLJ), Canoe EIT Income Fund (ENDTF), JPMorgan Emerging Markets Investment Trust (JMG), Fidelity China Special Situations (FCSS) and Syncona (SYNC).
View all of BIOG's competitors.
What other stocks do shareholders of The Biotech Growth Trust own?: Based on aggregate information from My MarketBeat watchlists, some companies that other The Biotech Growth Trust investors own include Solid Biosciences (SLDB), European Metals (EMH), Advanced Medical Solutions Group (AMS), National Grid (NG), Paysafe Group (PAYS), Polar Capital Technology Trust (PCT), Verona Pharma plc (VRP.L) (VRP), Fidelity China Special Situations (FCSS), abrdn Asia Focus (AAS) and CVS Group (CVSG).
What is The Biotech Growth Trust's stock symbol?: The Biotech Growth Trust trades on the London Stock Exchange (LON) under the ticker symbol "BIOG."
How do I buy shares of The Biotech Growth Trust?: Shares of BIOG and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.
What is The Biotech Growth Trust's stock price today?: One share of BIOG stock can currently be purchased for approximately GBX 835.
How much money does The Biotech Growth Trust make?: The Biotech Growth Trust has a market capitalization of £341.70 million and generates £-32.12 million in revenue each year.
What is The Biotech Growth Trust's official website?: The official website for The Biotech Growth Trust is www.biotechgt.com.
How can I contact The Biotech Growth Trust?: The Biotech Growth Trust's mailing address is 25 Southampton Buildings, LONDON, WC2A 1AL, United Kingdom. The company can be reached via phone at +44-20-74264000.

This page was last updated on 5/22/2022 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms

Your Ultimate Investing Toolkit

Just $1.00 for your first month.